223 related articles for article (PubMed ID: 22814437)
1. Replacement of huntingtin exon 1 by trans-splicing.
Rindt H; Yen PF; Thebeau CN; Peterson TS; Weisman GA; Lorson CL
Cell Mol Life Sci; 2012 Dec; 69(24):4191-204. PubMed ID: 22814437
[TBL] [Abstract][Full Text] [Related]
2. Optimization of
Rindt H; Tom CM; Lorson CL; Mattis VB
Front Neurosci; 2017; 11():544. PubMed ID: 29066943
[TBL] [Abstract][Full Text] [Related]
3. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.
Sathasivam K; Neueder A; Gipson TA; Landles C; Benjamin AC; Bondulich MK; Smith DL; Faull RL; Roos RA; Howland D; Detloff PJ; Housman DE; Bates GP
Proc Natl Acad Sci U S A; 2013 Feb; 110(6):2366-70. PubMed ID: 23341618
[TBL] [Abstract][Full Text] [Related]
4. 5' exon replacement and repair by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Clark RH; Puttaraju M; Kole J; Cohn JA; Mitchell LG; Garcia-Blanco MA
RNA; 2003 Oct; 9(10):1290-7. PubMed ID: 13130143
[TBL] [Abstract][Full Text] [Related]
5. Allele-specific silencing of mutant huntingtin in rodent brain and human stem cells.
Drouet V; Ruiz M; Zala D; Feyeux M; Auregan G; Cambon K; Troquier L; Carpentier J; Aubert S; Merienne N; Bourgois-Rocha F; Hassig R; Rey M; Dufour N; Saudou F; Perrier AL; Hantraye P; Déglon N
PLoS One; 2014; 9(6):e99341. PubMed ID: 24926995
[TBL] [Abstract][Full Text] [Related]
6. Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.
Mansfield SG; Kole J; Puttaraju M; Yang CC; Garcia-Blanco MA; Cohn JA; Mitchell LG
Gene Ther; 2000 Nov; 7(22):1885-95. PubMed ID: 11127576
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated silencing of huntingtin expression by shRNA.
Huang B; Kochanek S
Hum Gene Ther; 2005 May; 16(5):618-26. PubMed ID: 15916486
[TBL] [Abstract][Full Text] [Related]
8. Extensive Expression Analysis of Htt Transcripts in Brain Regions from the zQ175 HD Mouse Model Using a QuantiGene Multiplex Assay.
Papadopoulou AS; Gomez-Paredes C; Mason MA; Taxy BA; Howland D; Bates GP
Sci Rep; 2019 Nov; 9(1):16137. PubMed ID: 31695145
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis.
Gipson TA; Neueder A; Wexler NS; Bates GP; Housman D
RNA Biol; 2013 Nov; 10(11):1647-52. PubMed ID: 24256709
[TBL] [Abstract][Full Text] [Related]
10. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
11. Promiscuity of pre-mRNA spliceosome-mediated trans splicing: a problem for gene therapy?
Kikumori T; Cote GJ; Gagel RF
Hum Gene Ther; 2001 Jul; 12(11):1429-41. PubMed ID: 11485634
[TBL] [Abstract][Full Text] [Related]
12. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
[TBL] [Abstract][Full Text] [Related]
13. A Fresh Look at Huntingtin mRNA Processing in Huntington's Disease.
Romo L; Mohn ES; Aronin N
J Huntingtons Dis; 2018; 7(2):101-108. PubMed ID: 29865084
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel alternative splicing events in the huntingtin gene and assessment of the functional consequences using structural protein homology modelling.
Hughes AC; Mort M; Elliston L; Thomas RM; Brooks SP; Dunnett SB; Jones L
J Mol Biol; 2014 Apr; 426(7):1428-38. PubMed ID: 24389360
[TBL] [Abstract][Full Text] [Related]
15. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
[TBL] [Abstract][Full Text] [Related]
16. Aberrant splicing of mutant huntingtin in Huntington's disease knock-in pigs.
Tong H; Yang T; Liu L; Li C; Sun Y; Jia Q; Qin Y; Chen L; Zhao X; Zhou G; Yan S; Li XJ; Li S
Neurobiol Dis; 2023 Oct; 187():106291. PubMed ID: 37716514
[TBL] [Abstract][Full Text] [Related]
17. An alternative splicing modulator decreases mutant HTT and improves the molecular fingerprint in Huntington's disease patient neurons.
Krach F; Stemick J; Boerstler T; Weiss A; Lingos I; Reischl S; Meixner H; Ploetz S; Farrell M; Hehr U; Kohl Z; Winner B; Winkler J
Nat Commun; 2022 Nov; 13(1):6797. PubMed ID: 36357392
[TBL] [Abstract][Full Text] [Related]
18. A natural antisense transcript at the Huntington's disease repeat locus regulates HTT expression.
Chung DW; Rudnicki DD; Yu L; Margolis RL
Hum Mol Genet; 2011 Sep; 20(17):3467-77. PubMed ID: 21672921
[TBL] [Abstract][Full Text] [Related]
19. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
[TBL] [Abstract][Full Text] [Related]
20. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
